{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:33:23Z","timestamp":1787585603903,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000085","name":"OHTN","doi-asserted-by":"crossref","award":["EFP-1128-BNG"],"award-info":[{"award-number":["EFP-1128-BNG"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","award":["EFP-1128-BNG"],"award-info":[{"award-number":["EFP-1128-BNG"]}],"id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25205-7","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:45:54Z","timestamp":1780393554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the reach of pre-exposure prophylaxis services in suburban and rural Ontario: an implementation science evaluation of a public health-led model"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5845-4197","authenticated-orcid":false,"given":"Carmela","family":"Rapino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-3654","authenticated-orcid":false,"given":"Emma","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0224-379X","authenticated-orcid":false,"given":"Sahar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-405X","authenticated-orcid":false,"given":"Beatriz","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Szumlanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kamotho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-910X","authenticated-orcid":false,"given":"T. Hugh","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-7823","authenticated-orcid":false,"given":"Jorge","family":"Martinez-Cajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"25205_CR1","unstructured":"Public Health Agency ofCanada. HIV in Canada: 2023 surveillance highlights. 2024. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/hiv-2023-surveillance-highlights-infographic.html. Cited 2024 Dec 13."},{"issue":"47","key":"25205_CR2","doi-asserted-by":"publisher","first-page":"E1448","DOI":"10.1503\/cmaj.170494","volume":"189","author":"DHS Tan","year":"2017","unstructured":"Tan DHS, Hull MW, Yoong D, Tremblay C, O\u2019Byrne P, Thomas R, et al. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis. CMAJ. 2017;189(47):E1448\u201358.","journal-title":"CMAJ"},{"issue":"4","key":"25205_CR3","first-page":"496","volume":"158","author":"AR Rachlis","year":"1998","unstructured":"Rachlis AR, Zarowny DP, Working GCHTNA. Guidelines for antiretroviral therapy for HIV infection. CMAJ. 1998;158(4):496\u2013505.","journal-title":"CMAJ."},{"issue":"3","key":"25205_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.15171\/ijhpm.2019.93","volume":"9","author":"M Hajizadeh","year":"2020","unstructured":"Hajizadeh M, Edmonds S. Universal Pharmacare in Canada: A Prescription for Equity in Healthcare. Int J Health Policy Manag. 2020;9(3):91\u20135.","journal-title":"Int J Health Policy Manag"},{"issue":"1","key":"25205_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14745\/ccdr.v51i01a05","volume":"51","author":"N Popovic","year":"2025","unstructured":"Popovic N, Yang Q, Campeau L, Elliott J, Williams A, Lima VD, et al. The prevalence of HIV pre-exposure prophylaxis (HIV-PrEP) use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018\u20132021. Can Commun Dis Rep. 2025;51(1):35\u201342.","journal-title":"Can Commun Dis Rep"},{"key":"25205_CR6","unstructured":"Yoong D. Provincial\/territorial coverage of ARV drugs for HIV prevention across Canada: post\u2010exposure prophylaxis (PEP) and pre\u2010exposure prophylaxis (PrEP). 2018. Available from: https:\/\/hivclinic.ca\/wp-content\/uploads\/2018\/04\/ARV-Coverage_PEP-and-PrEP.pdf."},{"issue":"3","key":"25205_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248626","volume":"16","author":"M Charest","year":"2021","unstructured":"Charest M, Sharma M, Chris A, Schnubb A, Knox DC, Wilton J, et al. Decentralizing PrEP delivery: implementation and dissemination strategies to increase PrEP uptake among MSM in Toronto, Canada. PLoS ONE. 2021;16(3):e0248626.","journal-title":"PLoS ONE"},{"issue":"1","key":"25205_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3324-2","volume":"18","author":"M Sharma","year":"2018","unstructured":"Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, et al. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. BMC Health Serv Res. 2018;18(1):513.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"25205_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040817","volume":"11","author":"P O\u2019Byrne","year":"2021","unstructured":"O\u2019Byrne P, Vandyk A, Orser L, Haines M. Nurse-led PrEP-RN clinic: a prospective cohort study exploring task-shifting HIV prevention to public health nurses. BMJ Open. 2021;11(1):e040817.","journal-title":"BMJ Open"},{"issue":"6","key":"25205_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/phn.12813","volume":"37","author":"M Selfridge","year":"2020","unstructured":"Selfridge M, Card KG, Lundgren K, Barnett T, Guarasci K, Drost A, et al. Exploring nurse-led HIV pre-exposure prophylaxis in a community health care clinic. Public Health Nurs. 2020;37(6):871\u20139.","journal-title":"Public Health Nurs"},{"issue":"12","key":"25205_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1177\/1049732317716419","volume":"27","author":"BJ Klassen","year":"2017","unstructured":"Klassen BJ, Lachowsky NJ, Lin SY, Edwards JB, Chown SA, Hogg RS, et al. Gay men\u2019s understanding and education of new HIV prevention technologies in Vancouver. Canada Qual Health Res. 2017;27(12):1775\u201391.","journal-title":"Canada Qual Health Res"},{"issue":"4","key":"25205_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/QAI.0000000000002472","volume":"85","author":"Y Xia","year":"2020","unstructured":"Xia Y, Greenwald ZR, Milwid RM, Trottier C, Boissonnault M, Gaul N, et al. Pre-exposure prophylaxis uptake among men who have sex with men who used nPEP: a longitudinal analysis of attendees at a large sexual health clinic in Montr\u00e9al (Canada). JAIDS J Acquir Immune Defic Syndr. 2020;85(4):408.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"3","key":"25205_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/17151635231152218","volume":"156","author":"C Booker","year":"2023","unstructured":"Booker C, Murphy AL, Isenor JE, Ramsey TD, Smith AJ, Bishop A, et al. Community pharmacists\u2019 acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada. 2023;156(3):137\u201349.","journal-title":"Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"},{"issue":"4","key":"25205_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/17151635231177027","volume":"156","author":"CB MacDonald","year":"2023","unstructured":"MacDonald CB, Murphy AL, Isenor JE, Ramsey TD, Furlotte K, Smith AJ, et al. Target users\u2019 acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada. 2023;156(4):194\u2013203.","journal-title":"Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"},{"issue":"6","key":"25205_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1089\/apc.2023.0034","volume":"37","author":"D Grace","year":"2023","unstructured":"Grace D, Gaspar M, Wells A, Sinno J, Daroya E, Montess M, et al. Injectable pre-exposure prophylaxis for HIV prevention: perspectives on the benefits and barriers from gay, bisexual, and queer men and health system stakeholders in Ontario, Canada. AIDS Patient Care STDS. 2023;37(6):306\u201315.","journal-title":"AIDS Patient Care STDS"},{"key":"25205_CR16","unstructured":"Kroch A. HIV pre-exposure prophylaxis (PrEP) in Ontario, 2022. 2022; Available from: https:\/\/www.ohtn.on.ca\/wp-content\/uploads\/2024\/03\/OHTN-PrEP-report-2022.pdf."},{"key":"25205_CR17","unstructured":"Canada PHA of. HIV-PrEP use and HIV-PrEP-to-need ratio in nine Canadian provinces, 2018\u20132021, CCDR. 2025;51(1). Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/reports-publications\/canada-communicable-disease-report-ccdr\/monthly-issue\/2025-51\/issue-1-january-2025\/hiv-prep-use-need-ratio-nine-canadian-provinces-2018-2021.html. Cited 2025 May 8."},{"issue":"2","key":"25205_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.17269\/s41997-025-01009-5","volume":"116","author":"W Ajiboye","year":"2025","unstructured":"Ajiboye W, Tharao W, Owino M, Soje L, Tian JMLH, Ly A, et al. Racial disparities in HIV pre-exposure prophylaxis (PrEP) awareness and uptake among white, Black, and Indigenous men in Canada: analysis of data from the I\u2019m ready national HIV self-testing study. Can J Public Health. 2025;116(2):243\u201353.","journal-title":"Can J Public Health"},{"issue":"30","key":"25205_CR19","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.ssmph.2025.101771","volume":"10","author":"BD Adam","year":"2025","unstructured":"Adam BD, Monteza-Quiroz D, Hart TA, Skakoon-Sparling S, Moore DM, Zhang T, et al. Inequitable access to PrEP among gay, bisexual, and other men who have sex with men in Canada: A network analysis of social indicators. SSM Popul Health. 2025;10(30):101771.","journal-title":"SSM Popul Health"},{"issue":"9","key":"25205_CR20","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322\u20137.","journal-title":"Am J Public Health"},{"issue":"6","key":"25205_CR21","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.2105\/AJPH.2013.301299","volume":"103","author":"B Gaglio","year":"2013","unstructured":"Gaglio B, Shoup JA, Glasgow RE. The re-aim framework: a systematic review of use over time. Am J Public Health. 2013;103(6):e38-46.","journal-title":"Am J Public Health"},{"key":"25205_CR22","unstructured":"Government of Canada SC. Profile table, Census Profile, 2021 Census of Population - Kingston, Frontenac and Lennox and Addington Health Unit [Health region], Ontario. 2022. Available from: https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/dp-pd\/prof\/index.cfm?Lang=E. Cited 2025 May 8."},{"key":"25205_CR23","unstructured":"Government of Canada SC. Kingston, Ontario - Census metropolitan area - Focus on Geography Series - Census 2011. 2012. Available from: https:\/\/www12.statcan.gc.ca\/census-recensement\/2011\/as-sa\/fogs-spg\/Facts-cma-eng.cfm?LANG=Eng&GK=CMA&GC=521. Cited 2025 May 8."},{"key":"25205_CR24","unstructured":"Clinic Finder. Ontario PrEP Clinics. Available from: https:\/\/ontarioprep.ca\/clinic-finder\/. Cited 2025 Sept 22."},{"issue":"1","key":"25205_CR25","doi-asserted-by":"publisher","first-page":"e58976","DOI":"10.2196\/58976","volume":"14","author":"M Sohail","year":"2025","unstructured":"Sohail M, Matthews L, Williams A, Kempf MC, Phillips D, Goymer H, et al. Improving pre-exposure prophylaxis provision as part of routine gynecologic care among black cisgender women (Project PrEP4Her): protocol for the implementation of an intervention. JMIR Research Protocols. 2025;14(1):e58976.","journal-title":"JMIR Research Protocols"},{"issue":"4","key":"25205_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40264-017-0505-6","volume":"40","author":"RA Tetteh","year":"2017","unstructured":"Tetteh RA, Yankey BA, Nartey ET, Lartey M, Leufkens HGM, Dodoo ANO. Pre-exposure prophylaxis for HIV prevention: safety concerns. Drug Saf. 2017;40(4):273\u201383.","journal-title":"Drug Saf"},{"issue":"6","key":"25205_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028768","volume":"9","author":"ZR Greenwald","year":"2019","unstructured":"Greenwald ZR, Maheu-Giroux M, Szabo J, Robin JAB, Boissonnault M, Nguyen VK, et al. Cohort profile: l\u2019Actuel pre-exposure prophylaxis (PrEP) cohort study in Montreal, Canada. BMJ Open. 2019;9(6):e028768.","journal-title":"BMJ Open"},{"issue":"11","key":"25205_CR28","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1007\/s10461-021-03336-3","volume":"25","author":"S Colyer","year":"2021","unstructured":"Colyer S, Lachowsky NJ, Schmidt AJ, Adam BD, Paquette D, Hart TA, et al. Measures of HIV pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in Canada and demographic disparities among those at elevated likelihood for HIV acquisition. AIDS Behav. 2021;25(11):3638\u201350.","journal-title":"AIDS Behav"},{"issue":"30","key":"25205_CR29","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.ssmph.2025.101771","volume":"1","author":"BD Adam","year":"2025","unstructured":"Adam BD, Monteza-Quiroz D, Hart TA, Skakoon-Sparling S, Moore DM, Zhang T, et al. Inequitable access to PrEP among gay, bisexual, and other men who have sex with men in Canada: a network analysis of social indicators. SSM - Population Health. 2025;1(30):101771.","journal-title":"SSM - Population Health"},{"issue":"8","key":"25205_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/OLQ.0000000000001017","volume":"46","author":"AB Hoth","year":"2019","unstructured":"Hoth AB, Shafer C, Dillon DB, Mayer R, Walton G, Ohl ME. Iowa telePrEP: a public-health-partnered telehealth model for human immunodeficiency virus preexposure prophylaxis delivery in a rural state. Sex Transm Dis. 2019;46(8):507\u201312.","journal-title":"Sex Transm Dis"},{"issue":"12","key":"25205_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/OLQ.0000000000001872","volume":"50","author":"DM Higgins","year":"2023","unstructured":"Higgins DM, Riba A, Alderton L, Wendel KA, Scanlon J, Weise J, et al. Evaluation of the impact and outcomes of a rapid transition to telehealth PrEP delivery at a sexual health clinic during the COVID-19 pandemic. Sex Transm Dis. 2023;50(12):816\u201320.","journal-title":"Sex Transm Dis"},{"key":"25205_CR32","unstructured":"Ontario HIV Epidemiology and Surveillance Initiative. OHESI. 2024. OHESI - Ontario HIV Epidemiology and Surveillance Initiative. Available from: https:\/\/www.ohesi.ca\/.\u00a0Cited 2025 Sept 25."},{"key":"25205_CR33","unstructured":"OHESI. OHESI. OHESI - Ontario HIV Epidemiology and Surveillance Initiative. Available from:\u00a0https:\/\/www.ohesi.ca\/. Cited 2024 Aug 1."},{"issue":"3","key":"25205_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/QAD.0000000000001710","volume":"32","author":"N Lancki","year":"2018","unstructured":"Lancki N, Almirol E, Alon L, McNulty M, Schneider J. PrEP guidelines have low sensitivity for identifying seroconverters in a sample of young Black men who have sex with men in Chicago. AIDS. 2018;32(3):383\u201392.","journal-title":"AIDS"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25205-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:10:32Z","timestamp":1787584232000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25205-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25205"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25205-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research study was approved by the Queen\u2019s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board (HSERB) form (TRAQ# DMED-2650\u201322), in accordance with the Canadian Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans \u2013 TCPS 2.Use of electronic medical record data for secondary analysis was waived from obtaining informed participant consent under TCPS 2, Article 3.7A and Article 3.7B.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2430"}}